By Mill Chart
Last update: Jul 9, 2025
BIO-TECHNE CORP (NASDAQ:TECH) stands out as a potential candidate for quality investors, meeting key criteria for long-term growth and profitability. The company, a global life sciences firm, develops tools and reagents for research and diagnostics, positioning itself in a stable and expanding industry.
Our fundamental report rates TECH at 6 out of 10, with strengths in profitability and financial health. Key takeaways:
For investors seeking quality stocks with consistent performance, TECH presents a compelling case.
Our Caviar Cruise screener lists more quality investment opportunities and is updated regularly.
Disclaimer
This is not investment advice. Always conduct your own research before making investment decisions.
54.14
-0.27 (-0.5%)
Find more stocks in the Stock Screener
Stay updated with the movements of the S&P500 index one hour before the close of the markets on Thursday. Discover which stocks are leading as top gainers and losers in today's session.
Get insights into the S&P500 index performance on Thursday. Explore the top gainers and losers within the S&P500 index in today's session.
BIO-TECHNE CORP (NASDAQ:TECH) is a quality stock with strong revenue growth, high ROIC, and solid profitability, making it a candidate for long-term investors.
Curious about the S&P500 stocks that are in motion on Monday? Join us as we explore the top movers within the S&P500 index during today's session.
Curious about the S&P500 stocks that are in motion on Friday? Join us as we explore the top movers within the S&P500 index during today's session.
Let's take a look at the S&P500 stocks that are experiencing notable price gaps in today's session on Friday. Discover the gap up and gap down stocks in the S&P500 index.